Thrombocytopenia determination
US5466582A · kind A · utility
19Cited by
2References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 27, 1994 |
| Grant date | Nov 14, 1995 |
| Priority date | — |
| Expiry date | Sep 27, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/811
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to the determination of thrombocytopenia induced by an inductor drug such as heparin. According to the invention, a sample is mixed with a complex of an antigenic substance such as platelet factor 4 (pF4) and heparin to determine if the sample contains antibodies which react with the complex. The presence of these antibodies is indicative of heparin-induced thrombocytopenia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.